Thermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility

The pharmaceutical cold chain is entering a more demanding era. Networks are more complex and less predictable, distribution lanes are being reshaped by geopolitical and industrial change, and climate-driven disruptions are increasing in frequency and intensity. At the same time, the therapies moving through those networks are becoming more thermally sensitive and higher value, both in commercial terms, and in their significance to patients.

In that context, it is no longer sufficient to treat temperature protection as a packaging decision supported by a monitoring device. True performance depends on whether the entire shipment strategy has been designed around real-world operating conditions, and therefore whether teams can act on risk before it becomes loss, disruption or regulatory exposure.

This is why the industry is moving toward thermal assurance: a holistic approach that integrates high-performance thermal packaging, data-driven intelligence and human expertise into a single end-to-end framework.

Why visibility is no longer enough

Over the past decade, ‘visibility’ has been the dominant ambition in cold chain digitisation. Location tracking, temperature logging and exception alerts have improved transparency and helped organisations respond more quickly when issues arise.

However, visibility alone rarely improves performance. There are two fundamental reasons.

First, cold chain data is typically fragmented. A single shipment can involve multiple logistics partners, device providers, packaging strategies and operating systems. Even where information is available, it may not be connected in a way that supports decision-making.

Second, many systems remain descriptive rather than predictive. They show what has happened — and sometimes what is happening — but they do not consistently answer what matters most: what is likely to happen next, and what should we do about it now?

Thermal assurance requires a step-change from ‘seeing’ to ‘orchestrating’”

Thermal assurance requires a step-change from ‘seeing’ to ‘orchestrating’: combining multiple inputs, modelling exposure risk and prioritising intervention in a way that prevents excursions rather than documenting them.

Thermal assurance: the intersection of packaging, intelligence and expertise

It is important to be clear about what thermal assurance is, and what it is not.

It is not a replacement for thermal packaging. In fact, packaging remains the physical foundation of any temperature-controlled distribution strategy. The correct container, correctly configured and qualified, is still the first line of defence.

But packaging alone cannot compensate for flawed route assumptions or operational variability. Real supply chains rarely behave like qualification protocols. Flights are delayed. Customs holds overrun. Hand-off times extend unexpectedly. Weather exposure deviates from historical norms. Last-mile conditions are inconsistent. Even high-performing passive packaging can be placed under stress when lane design and contingency planning do not reflect reality.

Thermal assurance therefore emerges as an operating model that answers three linked questions: What protection does this product require on this lane, under these conditions? What risks are likely to emerge during transit, and how early can we detect them? What interventions are appropriate, and who has the authority and expertise to act?

From digitisation to orchestration: converting signals into outcomes

If visibility is the baseline, orchestration is the capability that creates value.

Orchestration integrates data from logistics systems, monitoring devices and external feeds (such as weather and lane conditions) and overlays it with modelling and contextual rules. The goal is not simply more information, but actionable intelligence that enables teams to identify threats earlier, prioritise the right shipments and intervene while options still exist.

This approach is increasingly attractive because it supports multiple outcomes at once, notably risk mitigation and product integrity. It also delivers faster, more confident exception handling; improved compliance documentation and operational control; packaging optimisation that reduces unnecessary cost and carbon burden; and continuous improvement through lane- and shipment-level learning.

In other words, orchestration turns cold chain management from a reactive function into a proactive, optimising discipline.

MedAssure: positioning orchestration within a thermal assurance ecosystem

Cold Chain Technologies (CCT) is launching MedAssure, a cold chain orchestration platform designed by cold chain experts and built specifically for the life sciences sector.

The strategic significance of a platform like MedAssure is not that it replaces existing systems, but that it can unify and interpret signals across them from first mile to last mile, across single-use and reusable packaging strategies, and across global and local supply models.

A key capability is the creation of custom Risk Profiles: allowing organisations to reflect their own operational vulnerabilities and risk tolerances, rather than relying on generic thresholds. Those profiles can then combine logistics data, live monitoring signals, weather insights and thermal modelling to identify when a shipment is trending toward risk — before that risk becomes an excursion or a downstream investigation.

This matters because the most costly cold chain failures rarely come from a lack of data. They come from late decisions, unclear ownership, and the inability to translate events into product impact quickly enough.

The role of thermal modelling in making packaging decisions smarter

Packaging selection is often treated as a fixed technical choice: select a qualified shipper with the required hold time, and assume the container will do the rest.

In practice, that approach can drive two costly failure modes.

The first is under-specification, where packaging capability does not match the true operational exposure on a lane. The flipside is over-specification, where the packaging provides reassurance but creates unnecessary cost, weight and environmental burden.

[Thermal modelling] enables more precise selection of container type and pack-out configuration — supporting both resilience and sustainability”

Thermal modelling helps escape that trade-off by linking laboratory qualification performance to route-specific variables: expected transit time, ambient exposure, hand-offs, infrastructure reliability, and seasonal conditions. It enables more precise selection of container type and pack-out configuration — supporting both resilience and sustainability.

When modelling is integrated into orchestration, it also supports better decision-making during disruption: teams can move from ’temperature breached’ to ’what is the likely stability impact given the exposure window, and what should we do next?’

Why human expertise remains decisive

The increasing sophistication of digital tools can create a tempting assumption: that enough data will eventually automate decision-making.

In the pharmaceutical cold chain, that assumption is risky.

Data can surface anomalies; it cannot always determine significance. The same event may have very different implications depending on product stability, packaging configuration, route context and downstream options. Human judgement remains essential — particularly in high-stakes moments where intervention decisions must be made quickly and defensibly.

This is why CCT has positioned MedAssure alongside Customer Assurance & Resource Excellence (C.A.R.E.) Services — providing specialist oversight that monitors shipments, interprets context and intervenes proactively.

Crucially, expert teams can intervene not only when systems flag an issue, but when experience indicates action is needed — for example, when a delay pattern suggests escalating exposure risk even before a temperature signal breaches a threshold.

This ‘human-in-the-loop’ model is also what enables continuous improvement. Shipment data only creates value if it is analysed, patterns are identified, and strategies are refined over time — from lane qualification and packaging selection to contingency planning and partner performance.

The wider value proposition: resilience, efficiency and sustainability

Thermal assurance is often framed primarily as a compliance and quality imperative. That is correct — but incomplete.

When packaging, digital intelligence and human expertise are aligned, thermal assurance becomes a lever for broader performance, enabling more predictable distribution under volatile conditions, better packaging and route optimisation (reducing cost and carbon burden). The outcomes are fewer deviations, less product waste and stronger supply continuity and patient access.

When packaging, digital intelligence and human expertise are aligned, thermal assurance [leads to] fewer deviations, less product waste and stronger supply continuity and patient access”

This matters because uncertainty is no longer episodic. It is structural. Organisations that can anticipate and manage risk across end-to-end distribution will be better positioned to scale advanced therapies, protect margins and maintain trust.

Thermal assurance is the next maturity step in cold chain management

The pharmaceutical cold chain is not simply becoming more complex; it is becoming more consequential. Products are more sensitive, routes are more variable, and the operational cost of failure is rising.

In this environment, the future of cold chain protection lies in integration: thermal packaging excellence supported by orchestration platforms that convert fragmented signals into early, defensible decisions — and backed by expert teams that can intervene effectively.

That is the practical meaning of thermal assurance as an operating model. It is not a single product, device or dashboard. It is a system of protection — designed to keep medicines safe, compliant and effective at every stage of their journey.